Pillar Clinical Research | Richardson, TX
Status and phase
Conditions
Treatments
About
This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
456 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Yuki Prescott
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal